S
Shattuck Labs D
D
STTK
0.94500
USD
-0.02
(-1.74%)
مفتوح الان
حجم التداول
388
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
45,268,538
العنوان: Shattuck Labs
القطاع: Healthcare
الصناعة: Biotechnology
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325,which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.